Lihua Du

1.3k total citations
28 papers, 1.1k citations indexed

About

Lihua Du is a scholar working on Oncology, Molecular Biology and Biomedical Engineering. According to data from OpenAlex, Lihua Du has authored 28 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 11 papers in Molecular Biology and 8 papers in Biomedical Engineering. Recurrent topics in Lihua Du's work include Nanoplatforms for cancer theranostics (8 papers), Blood disorders and treatments (7 papers) and Neutropenia and Cancer Infections (7 papers). Lihua Du is often cited by papers focused on Nanoplatforms for cancer theranostics (8 papers), Blood disorders and treatments (7 papers) and Neutropenia and Cancer Infections (7 papers). Lihua Du collaborates with scholars based in China, United States and Ukraine. Lihua Du's co-authors include Timothy C. Chambers, Christopher S. Lyle, Haozhe He, Xintao Shuai, Da Xing, Huan Qin, Teng Ma, Tao Zhang, Yongcheng An and Huihai Zhong and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Blood.

In The Last Decade

Lihua Du

26 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lihua Du China 16 514 426 237 217 176 28 1.1k
Quancheng Kan China 16 486 0.9× 352 0.8× 350 1.5× 206 0.9× 163 0.9× 30 1.2k
Xiuquan Luo United States 16 581 1.1× 204 0.5× 148 0.6× 140 0.6× 89 0.5× 22 1.0k
Mohammad Aminur Rahman United States 18 967 1.9× 318 0.7× 229 1.0× 132 0.6× 111 0.6× 41 1.5k
Pengfei Jiang China 19 451 0.9× 239 0.6× 137 0.6× 217 1.0× 125 0.7× 55 1.1k
Xiaohui Zheng China 20 712 1.4× 555 1.3× 192 0.8× 263 1.2× 211 1.2× 65 1.5k
Krishnendu Pal United States 20 607 1.2× 182 0.4× 280 1.2× 119 0.5× 89 0.5× 34 1.2k
Sriram S. Shanmugavelandy United States 17 542 1.1× 363 0.9× 94 0.4× 165 0.8× 90 0.5× 21 1.0k
Hongyan Cui China 20 521 1.0× 233 0.5× 119 0.5× 180 0.8× 102 0.6× 55 1.1k
Lina Xie China 17 317 0.6× 462 1.1× 260 1.1× 358 1.6× 215 1.2× 30 1.1k

Countries citing papers authored by Lihua Du

Since Specialization
Citations

This map shows the geographic impact of Lihua Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lihua Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lihua Du more than expected).

Fields of papers citing papers by Lihua Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lihua Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lihua Du. The network helps show where Lihua Du may publish in the future.

Co-authorship network of co-authors of Lihua Du

This figure shows the co-authorship network connecting the top 25 collaborators of Lihua Du. A scholar is included among the top collaborators of Lihua Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lihua Du. Lihua Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Du, Lihua, Huaping Huang, Wenqing Wang, et al.. (2025). Hyaluronic acid-modified MOF nanoparticles for encapsulating asparaginase in T-cell acute lymphoblastic leukemia treatment. Chinese Chemical Letters. 37(1). 111222–111222. 1 indexed citations
2.
Du, Lihua, Zhuoyuan Li, Yu Raymond Shao, et al.. (2024). Albumin-based co-loaded sonosensitizer and STING agonist nanodelivery system for enhanced sonodynamic and immune combination antitumor therapy. Journal of Controlled Release. 375. 524–536. 11 indexed citations
3.
Xia, Qing, et al.. (2024). Cuproptosis-associated ncRNAs predict breast cancer subtypes. PLoS ONE. 19(2). e0299138–e0299138. 5 indexed citations
4.
Xia, Qing, Zehua Wang, Jinze Shen, et al.. (2023). Disulfidptosis-associated lncRNAs predict breast cancer subtypes. Scientific Reports. 13(1). 16268–16268. 19 indexed citations
5.
He, Haozhe, Lihua Du, Yongcheng An, et al.. (2023). Triple Tumor Microenvironment‐Responsive Ferroptosis Pathways Induced by Manganese‐Based Imageable Nanoenzymes for Enhanced Breast Cancer Theranostics. Small Methods. 7(7). e2300230–e2300230. 38 indexed citations
6.
He, Haozhe, et al.. (2022). Programmable therapeutic nanoscale covalent organic framework for photodynamic therapy and hypoxia-activated cascade chemotherapy. Acta Biomaterialia. 149. 297–306. 43 indexed citations
7.
8.
He, Haozhe, Xindan Zhang, Lihua Du, et al.. (2022). Molecular imaging nanoprobes for theranostic applications. Advanced Drug Delivery Reviews. 186. 114320–114320. 53 indexed citations
9.
Jiang, Yanfeng, Zhiming Zeng, Li Ye, et al.. (2021). Efficacy and Safety of First-Line Chemotherapies for Patients With Advanced Biliary Tract Carcinoma: A Systematic Review and Network Meta-Analysis. Frontiers in Oncology. 11. 736113–736113. 9 indexed citations
10.
Blayney, Douglas W., Yuankai Shi, Igor Bondarenko, et al.. (2021). Head-to-head comparison of single agent (SA) plinabulin (Plin) versus pegfilgrastim (Peg) for the prevention of chemotherapy-induced neutropenia (CIN) in the phase 3 trial PROTECTIVE-1.. Journal of Clinical Oncology. 39(15_suppl). 547–547. 2 indexed citations
11.
12.
13.
Cimino, Patrick J., Lan Huang, Lihua Du, et al.. (2019). Plinabulin, an inhibitor of tubulin polymerization, targets KRAS signaling through disruption of endosomal recycling. Biomedical Reports. 10(4). 218–224. 29 indexed citations
14.
Liang, Hai‐Wei, Bin Luo, Lihua Du, et al.. (2019). Expression significance and potential mechanism of hypoxia‐inducible factor 1 alpha in patients with myelodysplastic syndromes. Cancer Medicine. 8(13). 6021–6035. 7 indexed citations
15.
Du, Lihua, Huan Qin, Teng Ma, Tao Zhang, & Da Xing. (2017). In Vivo Imaging-Guided Photothermal/Photoacoustic Synergistic Therapy with Bioorthogonal Metabolic Glycoengineering-Activated Tumor Targeting Nanoparticles. ACS Nano. 11(9). 8930–8943. 168 indexed citations
16.
Upreti, Meenakshi, Christopher S. Lyle, Brian Skaug, Lihua Du, & Timothy C. Chambers. (2006). Vinblastine-induced Apoptosis Is Mediated by Discrete Alterations in Subcellular Location, Oligomeric Structure, and Activation Status of Specific Bcl-2 Family Members. Journal of Biological Chemistry. 281(23). 15941–15950. 34 indexed citations
17.
Panta, Ganesh R., Lihua Du, Fiemu E. Nwariaku, & Lawrence T. Kim. (2005). Direct phosphorylation of proliferative and survival pathway proteins by RET. Surgery. 138(2). 269–274. 13 indexed citations
18.
Du, Lihua, et al.. (2004). Inhibition of Cell Proliferation and Cell Cycle Progression by Specific Inhibition of Basal JNK Activity. Journal of Biological Chemistry. 279(12). 11957–11966. 130 indexed citations
19.
20.
Lyle, Christopher S., et al.. (2003). The JNK, ERK and p53 pathways play distinct roles in apoptosis mediated by the antitumor agents vinblastine, doxorubicin, and etoposide. Biochemical Pharmacology. 66(3). 459–469. 119 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Quancheng Kan Breakdown of academic impact, for papers by Xiuquan Luo Breakdown of academic impact, for papers by Mohammad Aminur Rahman Breakdown of academic impact, for papers by Pengfei Jiang Breakdown of academic impact, for papers by Xiaohui Zheng Breakdown of academic impact, for papers by Krishnendu Pal Breakdown of academic impact, for papers by Sriram S. Shanmugavelandy Breakdown of academic impact, for papers by Hongyan Cui Breakdown of academic impact, for papers by Lina Xie
Rankless by CCL
2026